News Website

Oroxylin A may promote cell apoptosis and inhibit epithelial-mesenchymal transition in endometrial cancer, associated with the ERβ/PI3K/AKT pathway - Nature

Oroxylin A may promote cell apoptosis and inhibit epithelial-mesenchymal transition in endometrial cancer, associated with the ERβ/PI3K/AKT pathway Nature

Published: April 10, 2025, 6:55 a.m.

Read Full Article

Greens candidate blocked from forum as debate heats up over antisemitism - Herald Sun

Greens candidate blocked from forum as debate heats up over antisemitism Herald Sun

Published: April 9, 2025, 11:13 p.m.

Read Full Article

Fertility Care Concerns Linger As PWFA Regs Face Revision - Law360

Fertility Care Concerns Linger As PWFA Regs Face Revision Law360

Published: April 9, 2025, 10:11 p.m.

Read Full Article

Costco chaos as shoppers descend on new Ardeer warehouse - Herald Sun

Costco chaos as shoppers descend on new Ardeer warehouse Herald Sun

Published: April 9, 2025, 9:12 p.m.

Read Full Article

Ffion Lewis to leave WRU as scrum-half hints at Wales retirement - BBC

Ffion Lewis to leave WRU as scrum-half hints at Wales retirement BBC

Published: April 9, 2025, 8:25 p.m.

Read Full Article

Long-Term Follow-Up and Overall Survival in NRG258, a Randomized Phase III Trial of CRT vs Chemotherapy for Locally Advanced Endometrial Carcinoma - MedPage Today

Long-Term Follow-Up and Overall Survival in NRG258, a Randomized Phase III Trial of CRT vs Chemotherapy for Locally Advanced Endometrial Carcinoma MedPage Today

Published: April 9, 2025, 3:15 p.m.

Read Full Article

ASCO Reading Room | Daniela Matei on Chemotherapy for Stage III Endometrial Cancer - MedPage Today

ASCO Reading Room | Daniela Matei on Chemotherapy for Stage III Endometrial Cancer MedPage Today

Published: April 9, 2025, 3:15 p.m.

Read Full Article

Gesynta Pharma AB Appoints Eva Johnsson as new Chief Medical Officer (CMO) / VP Clinical Development - beQuoted

Gesynta Pharma AB Appoints Eva Johnsson as new Chief Medical Officer (CMO) / VP Clinical Development beQuoted

Published: April 9, 2025, 12:15 p.m.

Read Full Article

'Creepy daycare worker said she was happy when I miscarried - then she stole my daughter' - The Mirror

'Creepy daycare worker said she was happy when I miscarried - then she stole my daughter' The Mirror

Published: April 9, 2025, 11:28 a.m.

Read Full Article

The grim reason women are being overmedicated - The Advertiser

The grim reason women are being overmedicated The Advertiser

Published: April 9, 2025, 7:40 a.m.

Read Full Article

Latest Articles

Oroxylin A may promote cell apoptosis and inhibit epithelial-mesenchymal transition in endometrial cancer, associated with the ERβ/PI3K/AKT pathway - Nature

Greens candidate blocked from forum as debate heats up over antisemitism - Herald Sun

Fertility Care Concerns Linger As PWFA Regs Face Revision - Law360

Costco chaos as shoppers descend on new Ardeer warehouse - Herald Sun

Ffion Lewis to leave WRU as scrum-half hints at Wales retirement - BBC

Long-Term Follow-Up and Overall Survival in NRG258, a Randomized Phase III Trial of CRT vs Chemotherapy for Locally Advanced Endometrial Carcinoma - MedPage Today

ASCO Reading Room | Daniela Matei on Chemotherapy for Stage III Endometrial Cancer - MedPage Today

Gesynta Pharma AB Appoints Eva Johnsson as new Chief Medical Officer (CMO) / VP Clinical Development - beQuoted

'Creepy daycare worker said she was happy when I miscarried - then she stole my daughter' - The Mirror

The grim reason women are being overmedicated - The Advertiser

Subscribe to Our Newsletter